Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility
Cancer Diagnosis & Prognosis · 2024-09-01 · 4 (5) · 579-585
DOI: 10.21873/cdp.10366 ↗At a glance
Journal article in Cancer Diagnosis & Prognosis, published online on 2024-09-01. Written by Yu-Ting Chin and 10 co-authors. Institution: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C. Cited 3 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Background/Aim: The role of alcohol consumption and aldehyde dehydrogenase 2 (ALDH2) genotype in hepatocellular carcinoma (HCC) development remains uncertain. Materials and Methods: We conducted genotyping of the ALDH2 rs671 single nucleotide polymorphism in 298 patients with HCC and 889 non-cancerous healthy controls. We assessed associations stratified by sex and alcohol consumption status. Results: Distribution of ALDH2 rs671 variant genotypes differed significantly between HCC patients and controls (ptrend=0.0311). Logistic regression analyses indicated that compared to the wild-type GG genotype, the heterozygous variant AG genotype and homozygous variant AA genotype conferred 1.22- and 1.77-fold increases in HCC risk (p=0.1794 and 0.0150, respectively). Allelic frequency analysis showed that the A allele was associated with a 1.29-fold increased HCC risk (p=0.0123). Additionally, AA genotype carriers had significantly higher HCC risk than GG genotype carriers among males (p=0.0145) and non-alcohol drinkers (p
Subjects
Author keywords
Authors and institutions
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
- Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
- Division of Colon and Rectal Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.
- National Defense Medical Center, Taipei, Taiwan, R.O.C.
- Department of Pediatrics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, R.O.C.
- Department of Medicinal Botanicals and Foods on Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C.
Cite
APA
Chin, Y. T., Wu, M. H., Shih, H. Y., Tsai, C. W., Pei, J. S., Ke, T. W., Wang, Y. C., Hung, Y. C., Chen, J. C., Bau, D. T., & Chang, W. S. (2024). Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility. Cancer Diagnosis & Prognosis, 4(5), 579-585. https://doi.org/10.21873/cdp.10366
Vancouver
Chin YT, Wu MH, Shih HY, Tsai CW, Pei JS, Ke TW, et al. Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility. Cancer Diagnosis & Prognosis. 2024;4(5):579-585. doi:10.21873/cdp.10366
BibTeX
@article{Chin2024,
author = {Chin, Yu-Ting and Wu, Ming-Hsien and Shih, Hou-Yu and Tsai, Chia-Wen and Pei, Jen-Sheng and Ke, Tao-Wei and Wang, Yun-Chi and Hung, Yi-Chih and Chen, Jaw-Chyun and Bau, DA-Tian and Chang, Wen-Shin},
title = {Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility},
journal = {Cancer Diagnosis & Prognosis},
year = {2024},
volume = {4},
number = {5},
pages = {579--585},
doi = {10.21873/cdp.10366}
}
EUVIMED